Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial? - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Thrombosis Research Année : 2022

Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?

Fichier non déposé

Dates et versions

hal-03679317 , version 1 (26-05-2022)

Identifiants

  • HAL Id : hal-03679317 , version 1

Citer

B. Petit, S. Soudet, G. Poenou, E. Zarrat, T. Machuron, et al.. Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?. Thrombosis Research, 2022, 213 (2), pp.S30. ⟨hal-03679317⟩
15 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More